Applikon Biotechnology and Finesse, LLC have signed a licensing agreement for the TruBio O/S Bioreactor Control Operating System, a digitally enabled, fully configurable open process control system developed for the life science industry. This agreement will enable Applikon bioreactors with a Delta V controls solution from Emerson Process Management, as well as an optional embedded PI Enterprise Server with PI Historian, PI Datalink, PI Process Book, PI Batch and OPC-HDA for data management.

Applikon’s bioreactor design and manufacturing expertise, together with Finesse’s bioprocess control and automation proficiency, will create a new bioreactor product family that operates under a unified, plant-wide control system platform. TruBIO O/S will be offered on Applikon’s i-ControlXL controller and on TruLOGIC controller for migrations of Applikon 1010 and 1030 controllers.

“We look forward to an enduring and mutually beneficial partnership with Applikon,” stated Barbara Paldus, chief executive officer of Finesse. “The combination of TruBIO O/S with Applikon’s broad bioreactor/fermentor offering, including single-use Appliflex systems, vessels ranging from 1L glass to 300L stainless steel, as well as micro bioreactors, will provide the global life sciences market with a consistent solution set that is fully scalable from R&D to Process Development and into Manufacturing.”

Applikon president John Chory stated, “The collaboration with Finesse will now enable Applikon bioreactor control systems to also integrate a DeltaV solution into Applikon’s i-ControlXL thus offering complete controls solutions to its customers regardless of the technology platform they have or choose to adopt. The expertise that Finesse offers with DeltaV integration provides an added value permitting Applikon to offer customers a reliable and prompt solution to their comprehensive controls and implementation requirements.”